|
|
||||||||
-Chains and Closely Related
-Chains1
Section of Immunobiology, Yale University School of Medicine and Howard Hughes Medical Institute, New Haven, CT 06510
The TCR on CD4 T cells binds to and recognizes MHC class
II:antigenic peptide complexes through molecular contacts with the
peptide amino acid residues that face up and out of the peptide-binding
groove. This interaction primarily involves the
complementarity-determining regions (CDR) of the TCR
- and
-chains contacting up to five residues of the peptide. We have used
two TCRs that recognize the same antigenic peptide and have identical
V
8.2 chains, but differ in all three CDR of their related V
2
chains, to examine the fine specificity of the TCR:peptide contacts
that lead to activation. By generating a peptide library containing all
20 aa residues in the five potential TCR contact sites, we were able to
demonstrate that the two similar TCRs responded differentially when
agonist, nonagonist, and antagonist peptide functions were examined.
Dual substituted peptides containing an agonist residue at the N
terminus, which interacts with CDR2
, and an antagonist residue at
the C terminus, which interacts with the CDR3
, were used to show
that the nature of the overall signal through the TCR is determined by
a combination of the type of signal received through both the TCR
-
and
-chains.
This article has been cited by other articles:
![]() |
J. S. Rossman, N. G. Stoicheva, F. D. Langel, G. H. Patterson, J. Lippincott-Schwartz, and B. C. Schaefer POLKADOTS Are Foci of Functional Interactions in T-Cell Receptor-mediated Signaling to NF-{kappa}B Mol. Biol. Cell, May 1, 2006; 17(5): 2166 - 2176. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. I. Buzas, A. Hanyecz, Y. Murad, F. Hudecz, E. Rajnavolgyi, K. Mikecz, and T. T. Glant Differential Recognition of Altered Peptide Ligands Distinguishes Two Functionally Discordant (Arthritogenic and Nonarthritogenic) Autoreactive T Cell Hybridoma Clones J. Immunol., September 15, 2003; 171(6): 3025 - 3033. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |